BerandaORX • STO
add
Orexo AB
Tutup sebelumnya
kr 23,75
Rentang hari
kr 22,80 - kr 24,75
Rentang tahun
kr 12,50 - kr 43,40
Kapitalisasi pasar
808,76Â jt SEK
Volume Rata-Rata
36,52Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
STO
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (SEK) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 3,30Â jt | -97,94% |
Biaya operasional | 80,70Â jt | -66,63% |
Penghasilan bersih | 724,80Â jt | 723,22% |
Margin laba bersih | 21,96Â rb | 30.373,80% |
Penghasilan per saham | — | — |
EBITDA | -46,80Â jt | -550,00% |
Tarif pajak efektif | -0,09% | — |
Neraca
Total aset
Total liabilitas
| (SEK) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 912,40Â jt | 639,98% |
Total aset | 1,30Â M | 119,03% |
Total liabilitas | 812,20Â jt | 12,63% |
Total ekuitas | 490,60 jt | — |
Saham yang beredar | 34,71 jt | — |
Harga terhadap nilai buku | 1,68 | — |
Tingkat pengembalian aset | -21,96% | — |
Tingkat pengembalian modal | -32,02% | — |
Arus Kas
Perubahan kas bersih
| (SEK) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 724,80Â jt | 723,22% |
Kas dari operasi | 806,20Â jt | 12.903,23% |
Kas dari investasi | — | — |
Kas dari pembiayaan | 4,80Â jt | 197,96% |
Perubahan kas bersih | 806,70Â jt | 9.503,57% |
Arus kas bebas | 40,78Â jt | 427,83% |
Tentang
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
Didirikan
1995
Situs
Karyawan
72
